Loading...
XMEXMEDICAB
Market cap159mUSD
Dec 19, Last price  
33.32MXN
1D
-1.13%
1Q
11.07%
Jan 2017
-21.23%
Name

Medica Sur, S.A.B. De C.V.

Chart & Performance

D1W1MN
XMEX:MEDICAB chart
P/E
5.02
P/S
0.77
EPS
6.63
Div Yield, %
20.67%
Shrs. gr., 5y
-2.62%
Rev. gr., 5y
2.74%
Revenues
4.13b
+6.77%
971,319,4721,057,251,0981,224,235,6481,397,174,4901,556,154,7551,784,449,4111,822,723,9751,900,834,0932,089,975,6842,256,399,6122,292,095,9952,278,751,6022,590,272,6123,431,445,8463,607,605,8393,698,067,6774,466,185,9343,906,143,7753,867,922,4284,129,753,984
Net income
635m
-33.15%
136,251,977144,495,381194,246,154216,324,806193,732,240236,829,900231,326,985224,088,054300,513,456379,765,048349,084,341241,018,529142,634,010231,798,220169,295,459140,551,783558,827,8221,154,516,740949,802,530634,983,587
CFO
424m
+56.94%
263,322,012230,752,691311,868,812305,416,639306,190,243427,755,325316,393,450349,721,873344,107,405494,095,240474,579,657327,807,240198,782,141213,985,864305,898,124425,440,5801,101,315,918821,320,259270,090,208423,871,328
Dividend
May 14, 20241.5 MXN/sh
Earnings
Apr 29, 2025

Profile

Médica Sur, S.A.B. de C.V. operates as a healthcare institution in Mexico. The company offers bypass and gastric banding, cholecystectomy, inguinal hernia repair, liposculpture, breast cosmetic, stereotactic radio, hip arthroplasty, knee arthroscopy, shoulder arthroscopy, spine, lithiasis, radical prostatectomy, and prostate surgeries. It also provides radiotherapy, imaging, and checkup services, as well as medical insurance services. The company was incorporated in 1966 and is based in Mexico City, Mexico. Médica Sur, S.A.B. de C.V. is a subsidiary of Neuco, SA de CV.
URL
https://www.medicasur.com.mx/
IPO date
Mar 10, 1994
Employees
Domiciled in
MX
Incorporated in
MX

Valuation

Title
MXN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
4,129,754
6.77%
3,867,922
-0.98%
3,906,144
-12.54%
Cost of revenue
3,044,433
2,892,095
2,710,124
Unusual Expense (Income)
NOPBT
1,085,321
975,828
1,196,020
NOPBT Margin
26.28%
25.23%
30.62%
Operating Taxes
183,614
204,790
263,780
Tax Rate
16.92%
20.99%
22.05%
NOPAT
901,706
771,038
932,240
Net income
634,984
-33.15%
949,803
-17.73%
1,154,517
106.60%
Dividends
(659,252)
(3,019,929)
(161,680)
Dividend yield
15.03%
75.21%
2.69%
Proceeds from repurchase of equity
(429,077)
(206,226)
(80,458)
BB yield
9.78%
5.14%
1.34%
Debt
Debt current
40,151
31,619
41,597
Long-term debt
1,041,420
1,064,016
1,100,113
Deferred revenue
Other long-term liabilities
42,883
33,635
30,969
Net debt
376,828
(125,762)
(2,390,112)
Cash flow
Cash from operating activities
423,871
270,090
821,320
CAPEX
(213,636)
(186,451)
(150,791)
Cash from investing activities
234,178
732,847
2,559,253
Cash from financing activities
(1,174,702)
(3,313,363)
(421,596)
FCF
982,906
860,771
1,586,470
Balance
Cash
704,744
1,221,396
3,531,822
Long term investments
Excess cash
498,256
1,028,000
3,336,515
Stockholders' equity
1,708,659
1,930,237
4,275,517
Invested Capital
2,630,459
2,182,108
2,125,331
ROIC
37.47%
35.80%
27.97%
ROCE
34.69%
30.40%
21.90%
EV
Common stock shares outstanding
107,939
107,939
123,282
Price
40.63
9.22%
37.20
-23.61%
48.70
44.94%
Market cap
4,385,560
9.22%
4,015,330
-33.12%
6,003,821
44.94%
EV
4,763,346
3,890,524
3,614,665
EBITDA
1,263,936
1,145,096
1,473,400
EV/EBITDA
3.77
3.40
2.45
Interest
75,379
75,949
78,796
Interest/NOPBT
6.95%
7.78%
6.59%